Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors

Microbial Drug Resistance

Volumn 18, Issue 3, 2012, Pages 261-270

  Müller, Anna ^a   Ulm, Hannah ^a   Reder Christ, Katrin ^a   Sahl, Hans Georg ^a   Schneider, Tanja ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIDERMIN; LANTIBIOTIC; LIPID; NISIN; TEICHOIC ACID;

ARTICLE; BACTERIAL MEMBRANE; BIOSYNTHESIS; CONTROLLED STUDY; LIPID BILAYER; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LIPID INTERACTION; PROTEIN MOTIF; STOICHIOMETRY;

ACIDIC GLYCOSPHINGOLIPIDS; ANTI-BACTERIAL AGENTS; BACTERIOCINS; BINDING SITES; CELL WALL; CHROMATOGRAPHY, THIN LAYER; ESCHERICHIA COLI; GLYCOSPHINGOLIPIDS; LACTOBACILLUS; LIPID BILAYERS; MICROBIAL SENSITIVITY TESTS; MICROCOCCUS LUTEUS; NISIN; PEPTIDES; PEPTIDOGLYCAN; PROTEIN BINDING; TEICHOIC ACIDS; TERPENES; URIDINE DIPHOSPHATE N-ACETYLMURAMIC ACID;

POSIBACTERIA;

EID: 84862005216     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0242     Document Type: Article

References (41)

1. Asaduzzaman, S.M., and K. Sonomoto. 2009. Lantibiotics: diverse activities and unique modes of action. J. Biosci. Bioeng. 107:475-487.
2. Bierbaum, G., and H.G. Sahl. 2009. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10:2-18.
3. Bonelli, R.R., T. Schneider, H.G. Sahl, and I. Wiedemann. 2006. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode of action studies. Antimicrob. Agents Chemother. 50:1449-1457.
4. Bonev, B.B., E. Breukink, E. Swiezewska, B. De Kruijff, and A. Watts. 2004. Targeting extracellular pyrophosphates underpins the high selectivity of nisin. FASEB J 18:1862.
5. Bouhss, A., M. Crouvoisier, D. Blanot, and D. Mengin-Lecreulx. 2004. Purification and characterization of the bacterial MraY translocase catalyzing the first membrane step of peptidoglycan biosynthesis. J. Biol. Chem. 279:29974-29980.
6. Bouhss, A., A.E. Trunkfield, T.D.H. Bugg, and D. Mengin-Lecreulx. 2008. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol. Rev. 32:208-233.
7. Breukink, E., C. van Kraaij, A. van Dalen, R.A. Demel, R.J. Siezen, B- de Kruijff, and O.P. Kuipers. 1998. The orientation of nisin in membranes. Biochemistry 37:8153-8162.
8. Breukink, E., I. Wiedemann, C. Kraaij, O.P. Kuipers, H.G. Sahl, and B. De Kruijff. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286:2361.
9. Breukink, E., P. Ganz, B. de Kruijff, and J. Seelig. 2000. Binding of nisin Z to bilayer vesicles as determined with isothermal titration calorimetry. Biochemistry 39:10247-10254.
10. Brötz, H., M. Josten, I. Wiedemann, U. Schneider, F. Götz, G. Bierbaum, and H.G. Sahl. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327.
11. Brown, S., Y.H. Zhang, and S. Walker. 2008. A revised pathway proposed for Staphylococcus aureus wall teichoic acid biosynthesis based on in vitro reconstitution of the intracellular steps. Chem. Biol. 15:12-21.
12. Christ, K., H.H. Rüttinger, M. Höpfner, U. Rothe, and G. Bendas. 2005. The detection of UV-induced membrane damages by a combination of two biosensor techniques. Photochem. Photobiol. 81:1417-1423.
13. Christ K., I. Wiedemann, U. Bakowsky, H.G. Sahl, and G. Bendas. 2007. The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques. Biochim. Biophys. Acta 1768:694-704.
14. Dagert, M., and S.D. Ehrlich. 1979. Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene 6:23-28.
15. Driessen, A.J.M., H.W. van den Hooven, W. Kuiper, M. Van de Camp, H.G. Sahl, R.N.H. Konings, and W.N. Konings. 1995. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry 34:1606-1614.
16. Hasper, H.E., B. de Kruijff, and E. Breukink. 2004. Assembly and stability of nisin-lipid II pores. Biochemistry 43:11567-11575.
17. Hasper, H.E., N.E. Kramer, J.L. Smith, J.D. Hillman, C. Zachariah, O.P. Kuipers, B. de Kruijff, and E. Breukink. 2006. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313:1636-1637.
18. Hoffmann, A., U. Pag, I. Wiedemann, and H.G. Sahl. 2002. Combination of antibiotic mechanisms in lantibiotics. Farmaco 57:685-691.
19. Hooven, H.W., C.A.E.M. Spronk, M. Kamp, R.N.H. Konings, C.W. Hilbers, and F.J.M. Ven. 1996. Surface location and orientation of the lantibiotic nisin bound to membrane-mimicking micelles of dodecylphosphocholine and of sodium dodecylsulphate. Eur. J. Biochem. 235:394-403.
20. Hsu, S.T.D., E. Breukink, E. Tischenko, M.A.G. Lutters, B. De Kruijff, R. Kaptein, A.M.J.J. Bonvin, and N.A.J. Van Nuland. 2004. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11:963-967.
21. Jung, G. 1991. Lantibiotics-Ribosomally synthesized biologically active polypeptides containing sulfide bridges and α,β-didehydroamino acids. Angew. Chem. Int. Ed. Engl. 30:1051-1068.
22. Kuipers, O.P., H.S. Rollema, W.M. Yap, H.J. Boot, R.J. Siezen, and W.M. de Vos. 1992. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J. Biol. Chem. 267:24340-24346.
23. Ottenwälder, B., T. Kupke, S. Brecht, V. Gnau, J. Metzger, G. Jung, and F. Götz. 1995. Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl. Environ. Microbiol. 61:3894-3903.
24. Rogers, L. 1928. The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus. J. Bacteriol. 16:321.
25. Rollema, H.S., O.P. Kuipers, P. Both, W. De Vos, and R.J. Sieze. 1995. Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl. Environ. Microbiol. 61:2873-2878.
26. Rubinchik, E., T. Schneider, M. Elliott, W.R.P. Scott, J. Pan, C. Anklin, H. Yang, D. Dugourd, A. Müller, K. Gries, S.K. Straus, H.G. Sahl, and R.E.W. Hancock. 2011. Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. Antimicrob. Agents Chemother. 55:2743.
27. Ruhr, E., and H.G. Sahl. 1985. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother. 27:841.
28. Sahl, H.G., and G. Bierbaum. 1998. Lantibiotics: Biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu. Rev. Microbiol. 52:41-79.
29. Sahl, H.G., and H. Brandis. 1983. Efflux of low-Mr substances from the cytoplasm of sensitive cells caused by the staphylococcin-like agent Pep 5. FEMS Microbiol. Lett. 16:75-79.
30. Sahl, H.G., M. Kordel, and R. Benz. 1987. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin. Arch. Microbiol. 149:120-124.
31. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd edition. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
32. Schneider, T., K. Gries, M. Josten, I. Wiedemann, S. Pelzer, H. Labischinski, and H.G. Sahl. 2009. The lipopeptide antibiotic friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob. Agents Chemother. 53:1610-1618.
33. Schneider, T., T. Kruse, R. Wimmer, I. Wiedemann, V. Sass, U. Pag, A. Jansen, A.K. Nielsen, P.H. Mygind, D.S. Raventós, S. Neve, B. Ravn, A.M.J.J. Bonvin, L. De Maria, A.S. Andersen, L.K. Gammelgaard, H.G. Sahl, and H.H. Kristensen. 2010. Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science. 328:1168-1172.
34. Schneider, T., M.M. Senn, B. Berger-Bächi, A. Tossi, H.G. Sahl, and I. Wiedemann. 2004. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol. Microbiol. 53:675-685.
35. Schnell, N., K.D. Entian, U. Schneider, F. Götz, H. Zahner, R. Kellner, and G. Jung. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphiderings. Nature 333:276-278.
36. Simonis, D., J. Fritzsche, S. Alban, and G. Bendas. 2007. Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition. Biochemistry 46:6156-6164.
37. Stone, K.J., and J.L. Strominger. 1971. Mechanism of Action of Bacitracin: Complexation with Metal Ion and C55-Isoprenyl Pyrophosphate. Proc. Natl. Acad. Sci. 68:3223-3227.
38. Wiedemann, I., E. Breukink, C. van Kraaij, O.P. Kuipers, G. Bierbaum, B. De Kruijff, and H.G. Sahl. 2001. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276:1772-1779.
39. Wiedemann, I., T. Böttiger, R.R. Bonelli, T. Schneider, H.G. Sahl, and B. Martinez. 2006. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl. Environ. Microbiol. 72:2809-2814.
40. Willey, J.M., and W.A. van der Donk. 2007. Lantibiotics: Peptides of diverse structure and function. Annu. Rev. Microbiol. 61:477-501.
41. Xia, G., T. Kohler, and A. Peschel. 2010. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int. J. Med. Microbiol. 300:148-154.